Mark Noble, Executive Vice President of ETF Strategy at Horizons ETFs discusses the intersection between pot stocks and the burgeoning psychedelics sector with one of the first analysts to cover both spaces, Andrew Partheniou, Associate VP, Institutional Research at Stifel GMP. In this podcast, Mark and Andrew discuss technical approaches to evaluating companies in the cannabis and psychedelic sectors, the cross-border differences and challenges for Canadian LPs, U.S. MSOs and investors, as well as the state of current valuations and future revenue potential.